Achieving Home Discharge for Institutionally-bound Patients Alzheimer's Disease and Alzheimer's Disease Related Dementias

Overview

About this study

The purpose of this study is to develop a novel mCAT to assess subdomains of functional coginition relevant to safe home discharge for patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). The goal of Project HoPe is to avoid unnecessary discharges from hospitals to skilled nursing (SNF)  or other post-acute care (PAC) facilities for all patients, but particularly those with AD/ADRD. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria (Patient/Caregiver):

  • ≥ 18 years of age.
  • EHR-flagged as primarily English-speaking.
  • Must be able to participate in interviews or focus groups lasting up to 2 hours.
  • Patient or caregiver of patient recently discharged from acute care to home or SNF.
  • Patient or caregiver of patient with cognitive impairment (50% with an AD/ADRD diagnosis).

Inclusion Criteria (Clinician/Staff):

  • Over 18 years of age.
  • Primary language is English speaking.
  • Must be able to participate in interviews or focus groups lasting up to 2 hours.
  • Involved the discharge planning process for patients in acute care.

Exclusion Criteria: 

  • Acute intoxication.
  • Aggressive/combative behavior.
  • Interpreter requirement.
  • Patients hospitalized with a diagnosis of Traumatic Brain Injury (TBI).
  • Subject requests not to be audio recorded during interviews.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/5/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrea Cheville, M.D.

Open for enrollment

Contact information:

Amanda Nelson

(507) 538-4950

Nelson.Amanda2@mayo.edu

More information

Publications

Publications are currently not available